Mustafa Hatipoglu

Mustafa Hatipoglu

Auto-generated profile, based on publicly available information

Mustafa Hatipoglu

Department of Infectious Diseases and Clinical Microbiology, Çanakkale Military Hospital, Çanakkale, Turkey

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
MHMustafa Hatipoglu
Mustafa Hatipoglu
MMMesut Mutluoglu
Mesut Mutluoglu
VTVedat Turhan
Vedat Turhan
Günalp UzunGünalp Uzun
Günalp Uzun
BLBenjamin A. Lipsky
Benjamin A. Lipsky
GSGonul Sengoz
Gonul Sengoz

23 January 2014 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
MHM. Hatipoglu
M. Hatipoglu
MMM. Mutluoglu
M. Mutluoglu
Günalp UzunGünalp Uzun
Günalp Uzun
EKE. Karabacak
E. Karabacak
VTV. Turhan
V. Turhan
BLBenjamin A. Lipsky
Benjamin A. Lipsky

15 October 2013 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
VTVedat Turhan
Vedat Turhan
MMMesut Mutluoglu
Mesut Mutluoglu
AAAli Acar
Ali Acar
MHMustafa Hatipoglu
Mustafa Hatipoglu
YOYalcın Onem
Yalcın Onem
LGLevent Gorenek
Levent Gorenek
Introduction: In the present study, we sought to identify the bacterial organisms associated with diabetic foot infections (DFIs) and their antibiotic sensitivity profiles. Methodology: We retrospectively reviewed the records of wound cultures collected from diabetic patients with foot infections between May 2005 and July 2010. Results: We identified a total of 298 culture specimens (165 [55%] wound swab, 108 [36%] tissue samples, and 25 [9%] bone samples) from 107 patients (74 [69%] males and 33 [31%] females, mean age 62 ± 13 yr) with a DFI. Among all cultures 83.5% (223/267) were monomicrobial and 16.4% (44/267) were polymicrobial. Gram-negative bacterial isolates (n = 191; 61.3%) significantly outnumbered Gram-positive isolates (n = 121; 38.7%). The most frequently isolated bacteria were Pseudomonas species (29.8%), Staphylococcus aureus (16.7%), Enterococcus species (11.5%), Escherichia coli (7.1%), and Enterobacter species (7.1%), respectively. While 13.2% of the Gram-negative isolates were inducible beta-lactamase positive, 44.2% of Staphylococcus aureus isolates were methicillin resistant. Conclusions: Our results support the recent view that Gram-negative organisms, depending on the geographical location, may predominate in DFIs.

1 February 2014 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
HEHakan Erdem
Hakan Erdem
NENazif Elaldi
Nazif Elaldi
NÖNefise Öztoprak
Nefise Öztoprak
GSGonul Sengoz
Gonul Sengoz
OAOznur Ak
Oznur Ak
HVHaluk Vahaboglu
Haluk Vahaboglu
The aim of this study was to delineate mortality indicators in pneumococcal meningitis with special emphasis on therapeutic implications. This retrospective, multicenter cohort study involved a 15-year period (1998-2012). Culture-positive cases (n=306) were included solely from 38 centers. Fifty-eight patients received ceftriaxone plus vancomycin empirically. The rest were given a third-generation cephalosporin alone. Overall, 246 (79.1%) isolates were found to be penicillin-susceptible, 38 (12.2%) strains were penicillin-resistant, and 22 (7.1%) were oxacillin-resistant (without further minimum inhibitory concentration testing for penicillin). Being a critical case (odds ratio (OR) 7.089, 95% confidence interval (CI) 3.230-15.557) and age over 50 years (OR 3.908, 95% CI 1.820-8.390) were independent predictors of mortality, while infection with a penicillin-susceptible isolate (OR 0.441, 95% CI 0.195-0.996) was found to be protective. Empirical vancomycin use did not provide significant benefit (OR 2.159, 95% CI 0.949-4.912). Ceftriaxone alone is not adequate in the management of pneumococcal meningitis due to penicillin-resistant pneumococci, which is a major concern worldwide. Although vancomycin showed a trend towards improving the prognosis of pneumococcal meningitis, significant correlation in statistical terms could not be established in this study. Thus, further studies are needed for the optimization of pneumococcal meningitis treatment.

1 June 2013 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
SBSevket Balta
Sevket Balta
SDSait Demirkol
Sait Demirkol
MHMustafa Hatipoglu
Mustafa Hatipoglu
SASukru Ardic
Sukru Ardic
ZAZekeriya Arslan
Zekeriya Arslan
TCTurgay CELIK
Turgay CELIK

3 November 2016 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
ZKZehra Karacaer
Zehra Karacaer
BCBanu Cakir
Banu Cakir
HEHakan Erdem
Hakan Erdem
KUKenan Ugurlu
Kenan Ugurlu
GDGul Durmus
Gul Durmus
NONecati Ormeci
Necati Ormeci
The aim of this study was to assess health-related quality of life (HRQOL) among chronic hepatitis B (CHB) patients in Turkey and to study related factors. This multicenter study was carried out between January 01 and April 15, 2015 in Turkey in 57 centers. Adults were enrolled and studied in three groups. Group 1: Inactive HBsAg carriers, Group 2: CHB patients receiving antiviral therapy, Group 3: CHB patients who were neither receiving antiviral therapy nor were inactive HBsAg carriers. Study data was collected by face-to-face interviews using a standardized questionnaire, Short Form-36 (SF-36) and Hepatitis B Quality of Life (HBQOL). Values equivalent to p < 0.05 in analyses were accepted as statistically significant. Four thousand two hundred fifty-seven patients with CHB were included in the study. Two thousand five hundred fifty-nine (60.1 %) of the patients were males. Groups 1, 2 and 3, consisted of 1529 (35.9 %), 1721 (40.4 %) and 1007 (23.7 %) patients, respectively. The highest value of HRQOL was found in inactive HBsAg carriers. We found that total HBQOL score increased when antiviral treatment was used. However, HRQOL of CHB patients varied according to their socio-demographic properties. Regarding total HBQOL score, a higher significant level of HRQOL was determined in inactive HBV patients when matched controls with the associated factors were provided. The HRQOL score of CHB patients was higher than expected and it can be worsen when the disease becomes active. Use of an antiviral therapy can contribute to increasing HRQOL of patients.